Literature DB >> 28032679

ACR appropriateness criteria® nasal cavity and paranasal sinus cancers.

Farzan Siddiqui1, Richard V Smith2, Sue S Yom3, Jonathan J Beitler4, Paul M Busse5, Jay S Cooper6, Ehab Y Hanna7, Christopher U Jones8, Shlomo A Koyfman9, Harry Quon10, John A Ridge11, Nabil F Saba12, Francis Worden13, Min Yao14, Joseph K Salama15.   

Abstract

The American College of Radiology (ACR) Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer-reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment. Here, we present the Appropriateness Criteria for cancers arising in the nasal cavity and paranasal sinuses (maxillary, sphenoid, and ethmoid sinuses). This includes clinical presentation, prognostic factors, principles of management, and treatment outcomes. Controversies regarding management of cervical lymph nodes are discussed. Rare and unusual nasal cavity cancers, such as esthesioneuroblastoma and sinonasal undifferentiated carcinomas, are included.
© 2016 American College of Radiology. Head Neck, 2016 © 2016 Wiley Periodicals, Inc. Head Neck 39: 407-418, 2017. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  Appropriateness Criteria; esthesioneuroblastoma; nasal cavity cancer; paranasal sinus cancer; sinonasal undifferentiated carcinoma

Mesh:

Year:  2016        PMID: 28032679     DOI: 10.1002/hed.24639

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  5 in total

1.  Organ preservation for patients with anterior mucosal squamous cell carcinoma of the nasal cavity: Rhinectomy-free survival in those refusing surgery.

Authors:  Ximena Mimica; Yao Yu; Marlena McGill; Christopher A Barker; Sean McBride; Ian Ganly; Jennifer R Cracchiolo; Lara A Dunn; Nora Katabi; Kevin Sine; Dennis Mah; Anna Lee; Nancy Lee; Marc A Cohen
Journal:  Head Neck       Date:  2019-04-01       Impact factor: 3.147

2.  Outcomes and toxicities of definitive radiotherapy and reirradiation using 3-dimensional conformal or intensity-modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignancies.

Authors:  Ming Fan; Jung Julie Kang; Anna Lee; Dan Fan; Huili Wang; Sarin Kitpanit; Pamela Fox; Kevin Sine; Dennis Mah; Sean M McBride; Chiaojung Jillian Tsai; Nadeem Riaz; Lara A Dunn; Eric J Sherman; Loren Michel; Bhuvanesh Singh; Ian Ganly; Richard J Wong; Jay O Boyle; Marc A Cohen; Nancy Y Lee
Journal:  Cancer       Date:  2020-02-25       Impact factor: 6.860

Review 3.  Radiation therapy strategies for skull-base malignancies.

Authors:  J D Palmer; M E Gamez; K Ranta; H Ruiz-Garcia; J L Peterson; D M Blakaj; D Prevedello; R Carrau; A Mahajan; K L Chaichana; D M Trifiletti
Journal:  J Neurooncol       Date:  2020-08-12       Impact factor: 4.130

4.  Invasion of the pterygoid plates: an indicator for regional lymph node failure in maxillary sinus cancer.

Authors:  Yasuo Kosugi; Terufumi Kawamoto; Masaki Oshima; Mitsuhisa Fujimaki; Shinichi Ohba; Fumihiko Matsumoto; Naoto Shikama; Keisuke Sasai
Journal:  Radiat Oncol       Date:  2021-01-06       Impact factor: 3.481

5.  Radiologic criteria of retropharyngeal lymph node metastasis in maxillary sinus cancer.

Authors:  Yasuo Kosugi; Michimasa Suzuki; Mitsuhisa Fujimaki; Shinichi Ohba; Fumihiko Matsumoto; Yoichi Muramoto; Terufumi Kawamoto; Masaki Oshima; Naoto Shikama; Keisuke Sasai
Journal:  Radiat Oncol       Date:  2021-09-26       Impact factor: 3.481

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.